The Southern Shrimp Alliance has criticized the FDA for failing to address an "unprecedented amount" of banned antibiotics in imported Indonesian shrimp, according to an Oct. 7 statement by the group.
On Oct. 3, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Oct. 2, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
Starting Oct. 31, the FDA will require import certification for shrimp and spices from certain regions of Indonesia, citing a perceived contamination risk of food with Cesium-137, the FDA said on Oct. 3.
On Sept. 30, the FDA posted new and revised versions of the following Import Alerts (after not having posted new ones for a number of days) on the detention without physical examination of:
On Sept. 29, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Sept. 26, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Sept. 25, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Sept. 24, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Sept. 23, the FDA posted new and revised versions of the following Import Alerts (after not having posted new ones for a number of days) on the detention without physical examination of: